T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$3.36B |
| 2 |
UnitedHealth
UNH
|
+$2.85B |
| 3 |
Salesforce
CRM
|
+$2.23B |
| 4 |
Philip Morris
PM
|
+$1.3B |
| 5 |
Sherwin-Williams
SHW
|
+$1.23B |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$3.71B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.75B |
| 3 |
GE Aerospace
GE
|
+$1.88B |
| 4 |
HCA Healthcare
HCA
|
+$1.7B |
| 5 |
American International
AIG
|
+$1.48B |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.06% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
2351
DELISTED
Cymabay Therapeutics
CBAY
| $360K | ﹤0.01% |
122,200
+12,077
| +11% | +$35.6K |
|
2352
Cars.com
CARS
$823M
| $359K | ﹤0.01% |
38,055
+12,600
| +49% | +$119K |
|
2353
Cimpress
CMPR
$1.48B
| $358K | ﹤0.01% |
9,207
+698
| +8% | +$27.1K |
|
2354
Pitney Bowes
PBI
$1.94B
| $358K | ﹤0.01% |
98,936
-3,904
| -4% | -$14.1K |
|
|
SHYF
2355
DELISTED
The Shyft Group
SHYF
| $358K | ﹤0.01% |
19,255
+218
| +1% | +$4.05K |
|
|
ARR
2356
Armour Residential REIT
ARR
$1.74B
| $357K | ﹤0.01% |
10,138
+343
| +4% | +$12.1K |
|
2357
Gorman-Rupp
GRC
$1.13B
| $357K | ﹤0.01% |
12,616
+3,818
| +43% | +$108K |
|
|
TRTX
2358
TPG RE Finance Trust
TRTX
$751M
| $357K | ﹤0.01% |
39,577
+1,139
| +3% | +$10.3K |
|
|
CANO
2359
DELISTED
Cano Health, Inc.
CANO
| $356K | ﹤0.01% |
812
+311
| +62% | +$136K |
|
2360
The Greenbrier Companies
GBX
$1.43B
| $354K | ﹤0.01% |
9,848
+151
| +2% | +$5.43K |
|
2361
Energy Recovery
ERII
$775M
| $352K | ﹤0.01% |
18,125
+1,595
| +10% | +$31K |
|
2362
Stewart Information Services
STC
$2.06B
| $351K | ﹤0.01% |
7,057
+248
| +4% | +$12.3K |
|
2363
LendingTree
TREE
$986M
| $351K | ﹤0.01% |
8,007
+1,462
| +22% | +$64.1K |
|
2364
TrueCar
TRUE
$194M
| $351K | ﹤0.01% |
135,557
+5,238
| +4% | +$13.6K |
|
2365
Century Aluminum
CENX
$2.15B
| $350K | ﹤0.01% |
47,504
+8,778
| +23% | +$64.7K |
|
2366
8x8 Inc
EGHT
$288M
| $346K | ﹤0.01% |
67,209
+20,328
| +43% | +$105K |
|
|
DX
2367
Dynex Capital
DX
$1.66B
| $345K | ﹤0.01% |
21,697
+168
| +0.8% | +$2.67K |
|
|
AAN
2368
DELISTED
The Aaron's Company, Inc.
AAN
| $345K | ﹤0.01% |
23,703
+133
| +0.6% | +$1.94K |
|
2369
Atara Biotherapeutics
ATRA
$82.5M
| $344K | ﹤0.01% |
1,765
+618
| +54% | +$120K |
|
2370
Pulmonx
LUNG
$66.8M
| $344K | ﹤0.01% |
23,363
+2,377
| +11% | +$35K |
|
|
ORC
2371
Orchid Island Capital
ORC
$1.04B
| $344K | ﹤0.01% |
24,148
+6,701
| +38% | +$95.5K |
|
|
UHT
2372
Universal Health Realty Income Trust
UHT
$573M
| $341K | ﹤0.01% |
6,409
+88
| +1% | +$4.68K |
|
2373
Hyliion Holdings
HYLN
$291M
| $340K | ﹤0.01% |
105,463
-12,978
| -11% | -$41.8K |
|
|
LBAI
2374
DELISTED
Lakeland Bancorp Inc
LBAI
| $339K | ﹤0.01% |
23,175
+2,795
| +14% | +$40.9K |
|
|
INN
2375
Summit Hotel Properties
INN
$619M
| $338K | ﹤0.01% |
46,468
-1,525,020
| -97% | -$11.1M |
|